Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Elections Medical Device Policy

Will US FDA Wind Up With More Political Positions Under Trump?

  • Analysis

Executive Summary

Incoming administration could appoint key legal and policy positions to shape agendas.

You may also be interested in...



Gottlieb Joins HHS Transition Team; Will Next Stop Be FDA?

Former US FDA, CMS official has been among those thought to be in the running for Trump's FDA commissioner nomination.

False Claims, Enforcement Changes Possible Under Trump Administration

Pharma lawyers suggest that much depends on who is selected for key posts – except for the Supreme Court.

White House Expands Reach Into FDA: External Affairs Head Is Skladany

FDA Senior Associate Commissioner for External Relations Linda Skladany is a veteran of half-a-dozen political appointments in the Reagan/Bush Administration

Table

View full table

Topics

Tags:
Elections Medical Device Policy
Latest Headlines

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

UK MHRA Updates Assistive Tech And Borderline Regulations

See All
UsernamePublicRestriction

Register

MT104176

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By